Crown Bioscience is a global contract research organization (CRO) headquartered in California that specializes in translational oncology and immuno-oncology drug discovery and development. The company provides comprehensive discovery, preclinical, and translational research platforms.
Subscribe to see Crown Bioscience’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Crown Bioscience is a biotechnology company headquartered in United States, founded in 2006. Its most recent funding round, Series B, raised $3M in February 2008. Xcout tracks 10 named people at Crown Bioscience, including John Gu (Chief Executive Officer and Chief Operating Officer).
4 more named people on record for Crown Bioscience, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.